Jeffrey Robert Ajer, EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 5,998 shares at $79.56 ($477K) on 2022-03-30, disclosed to the SEC on 2022-03-31.
Seasonal sale ($477k) by EVP, Chief Commercial Officer — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.43 | 1,618 | $129K | 27.0% |
| 2 | $79.43 | 1,618 | $129K | 27.0% |
| 3 | $79.56 | 1,381 | $110K | 23.0% |
| 4 | $79.56 | 1,381 | $110K | 23.0% |
| Total | $79.49 avg | 5,998 | $477K | 100% |
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |